{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:07:00Z","timestamp":1788286020449,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR071491"],"award-info":[{"award-number":["R01 AR071491"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Yale Center for Mendelian Genomics","award":["U54 HG006504"],"award-info":[{"award-number":["U54 HG006504"]}]},{"name":"Davidoff Foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jaad.2019.08.043","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T19:45:49Z","timestamp":1566589549000},"page":"123-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Topical cholesterol\/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy"],"prefix":"10.1016","volume":"82","author":[{"given":"Lihi","family":"Atzmony","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young H.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan S.","family":"Leventhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Choate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2019.08.043_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/DAD.0000000000000039","article-title":"Cornoid Lamellation Revisited: apropos of porokeratosis with emphasis on unusual clinicopathological variants","volume":"37","author":"Biswas","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2019.08.043_bib2","doi-asserted-by":"crossref","first-page":"24226","DOI":"10.1038\/srep24226","article-title":"Loss-of-function mutation in PMVK causes autosomal dominant disseminated superficial porokeratosis","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.jaad.2019.08.043_bib3","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/ng.2409","article-title":"Exome sequencing identifies\u00a0MVK mutations in disseminated superficial actinic porokeratosis","volume":"44","author":"Zhang","year":"2012","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.jaad.2019.08.043_bib4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/1346-8138.14343","article-title":"Mutations in mevalonate pathway genes in patients with familial or sporadic porokeratosis","volume":"45","author":"Leng","year":"2018","journal-title":"J\u00a0Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.043_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1524-4725.1996.tb00327.x","article-title":"Porokeratosis and cutaneous malignancy: a review","volume":"22","author":"Sasson","year":"1996","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2019.08.043_bib6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2340\/00015555-3123","article-title":"Skin cancer associated genodermatoses: a literature review","volume":"99","author":"Schierbeck","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.043_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12552","article-title":"Amelanotic melanoma arising within a lesion of disseminated superficial actinic porokeratosis: an unusual presentation leading to a novel therapeutic approach","volume":"31","author":"Al-Haseni","year":"2018","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.043_bib8","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s40257-017-0271-3","article-title":"Treatment of porokeratosis: a systematic review","volume":"18","author":"Weidner","year":"2017","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2019.08.043_bib9","doi-asserted-by":"crossref","first-page":"e06322","DOI":"10.7554\/eLife.06322","article-title":"Genomic variations of the mevalonate pathway in porokeratosis","volume":"4","author":"Zhang","year":"2015","journal-title":"eLife"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.043_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jamadermatol.2019.0016","article-title":"Second-hit, postzygotic PMVK and MVD mutations in linear porokeratosis","volume":"155","author":"Atzmony","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2019.08.043_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2019.05.020","article-title":"Clonal expansion of second-hit cells with somatic recombinations or C>T transitions form porokeratosis in MVD or MVK mutant heterozygotes","author":"Kubo","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"6257","key":"10.1016\/j.jaad.2019.08.043_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.jaad.2019.08.043_bib13","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1158\/1078-0432.CCR-12-0489","article-title":"Novel aspects of mevalonate pathway inhibitors as antitumor agents","volume":"18","author":"Thurnher","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.043_bib14","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/jid.2009.415","article-title":"Inhibition of Akt signaling by exclusion from lipid rafts in normal and transformed epidermal keratinocytes","volume":"130","author":"Calay","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.043_bib15","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1046\/j.1365-2133.2002.04853.x","article-title":"Premature apoptosis of keratinocytes and the dysregulation of\u00a0keratinization in porokeratosis","volume":"147","author":"Shen","year":"2002","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.jaad.2019.08.043_bib16","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/jid.2011.189","article-title":"Pathogenesis-based therapy reverses cutaneous abnormalities in an inherited disorder of distal cholesterol metabolism","volume":"131","author":"Paller","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.043_bib17","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1523-1747.1998.00386.x","article-title":"Recessive x-linked ichthyosis: role of cholesterol-sulfate accumulation in the barrier abnormality","volume":"111","author":"Zettersten","year":"1998","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.043_bib18","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1194\/jlr.R800002-JLR200","article-title":"Thematic review series: skin lipids. Pathogenesis of permeability barrier abnormalities in the ichthyoses: inherited disorders of lipid metabolism","volume":"49","author":"Elias","year":"2008","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.043_bib19","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1001\/archderm.1993.01680270066008","article-title":"Exogenous lipids influence permeability barrier recovery in acetone-treated murine skin","volume":"129","author":"Man","year":"1993","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2019.08.043_bib20","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archderm.1995.01690190063012","article-title":"Exogenous nonphysiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction","volume":"131","author":"Mao-Qiang","year":"1995","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.043_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1194\/jlr.R009548","article-title":"Malformation syndromes caused by disorders of cholesterol synthesis","volume":"52","author":"Porter","year":"2011","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.043_bib22","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/ajmg.a.38619","article-title":"CHILD syndrome: a modified pathogenesis-targeted therapeutic approach","volume":"176","author":"Bergqvist","year":"2018","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jaad.2019.08.043_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/TACG.S93933","article-title":"Mevalonate kinase deficiency: current perspectives","volume":"9","author":"Favier","year":"2016","journal-title":"Appl Clin Genet"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.043_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cell.2017.11.025","article-title":"Metabolic induction of trained immunity through the mevalonate pathway","volume":"172","author":"Bekkering","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.043_bib25","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clpt.2004.01.012","article-title":"Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and\u00a0periodic fever syndrome","volume":"75","author":"Simon","year":"2004","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jaad.2019.08.043_bib26","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/j.ejim.2008.04.009","article-title":"A patient with hyper-IgD syndrome responding to simvastatin treatment","volume":"19","author":"Attout","year":"2008","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.043_bib27","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1542\/peds.91.5.915","article-title":"Clinical and biochemical phenotype in 11 patients with mevalonic aciduria","volume":"91","author":"Hoffmann","year":"1993","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.043_bib28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2249.2006.03258.x","article-title":"Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T\u00a0cells in the skin","volume":"147","author":"Sugita","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.043_bib29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/1523-1747.ep12461153","article-title":"The lovastatin-treated rodent: a new model of barrier disruption and epidermal hyperplasia","volume":"96","author":"Feingold","year":"1991","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.043_bib30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/1523-1747.ep12555880","article-title":"Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis","volume":"98","author":"Menon","year":"1992","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.043_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0560.1991.tb01231.x","article-title":"Morphogenesis of the cornoid lamella: histochemical, immunohistochemical, and ultrastructural study of porokeratosis","volume":"18","author":"Ito","year":"1991","journal-title":"J Cutan Pathol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.043_bib32","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jdcr.2017.11.019","article-title":"Pathogenesis-based therapy: cutaneous abnormalities of CHILD syndrome successfully treated with topical simvastatin monotherapy","volume":"4","author":"Bajawi","year":"2018","journal-title":"JAAD Case Rep"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219326489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219326489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:53:39Z","timestamp":1759272819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219326489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0190962219326489"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.08.043","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical cholesterol\/lovastatin for the treatment of porokeratosis: A pathogenesis-directed therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.08.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}